1700 related articles for article (PubMed ID: 8638607)
21. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
22. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma.
Ilyas M; Niedobitek G; Agathanggelou A; Barry RE; Read AE; Tierney R; Young LS; Rooney N
J Pathol; 1995 Oct; 177(2):115-22. PubMed ID: 7490676
[TBL] [Abstract][Full Text] [Related]
24. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Bar virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype.
DiGiuseppe JA; Wu TC; Zehnbauer BA; McDowell PR; Barletta JM; Ambinder RF; Mann RB
Mod Pathol; 1995 Jun; 8(5):553-9. PubMed ID: 7675777
[TBL] [Abstract][Full Text] [Related]
26. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
28. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
[TBL] [Abstract][Full Text] [Related]
30. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations.
Anagnostopoulos I; Hummel M; Kaudewitz P; Korbjuhn P; Leoncini L; Stein H
Br J Dermatol; 1996 Feb; 134(2):276-81. PubMed ID: 8746341
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
32. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
33. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
34. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
35. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
36. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation.
Copie-Bergman C; Niedobitek G; Mangham DC; Selves J; Baloch K; Diss TC; Knowles DN; Delsol G; Isaacson PG
J Pathol; 1997 Nov; 183(3):287-92. PubMed ID: 9422983
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
[TBL] [Abstract][Full Text] [Related]
40. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
